Veiko Vasar
31 Raja Street
Raja, 50417, Estonia
Raja, 50417, Estonia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Antipsychotic treatment is associated with inflammatory and metabolic biomarkers alterations among first-episode psychosis patients: A 7-month follow-up study.
Journal: Early intervention in psychiatry
Published: October 25, 2016
Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients.
Journal: Oxidative medicine and cellular longevity
Published: February 11, 2016
Inflammatory, cardio-metabolic and diabetic profiling of chronic schizophrenia.
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: January 26, 2016
Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.
Journal: Schizophrenia research
Published: February 26, 2015
Associations between polymorphisms of LSAMP gene and schizophrenia.
Journal: Psychiatry research
Published: October 09, 2013
Social support in depression: structural and functional factors, perceived control and help-seeking.
Social support in depression: structural and functional factors, perceived control and help-seeking.
Journal: Epidemiology and psychiatric sciences
Published: September 26, 2013
Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression.
Journal: Journal of psychopharmacology (Oxford, England)
Published: August 09, 2013
Polymorphisms of IKBKE gene are associated with major depressive disorder and panic disorder.
Journal: Brain and behavior
Published: March 13, 2013
A survey of parentally reported sleep health disorders in Estonian 8-9 year old children.
Journal: BMC pediatrics
Published: February 17, 2013
Associations between LSAMP gene polymorphisms and major depressive disorder and panic disorder.
Journal: Translational psychiatry
Published: August 16, 2012
The effect of 6-week treatment with escitalopram on CCK-4 challenge: a placebo-controlled study in CCK-4-sensitive healthy volunteers.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: March 31, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026